share_log

加拿大蒙特利尔银行:重申Acrivon Therapeutics(ACRV.US)评级,由优于大市调整至优于大市评级, 目标价由25.00美元调整至25.00美元。

Bank of Montreal, Canada: Reiterated the Acrivon Therapeutics (ACRV.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $25.00 to $25.00.

Zhitong Finance ·  May 15 21:03
Bank of Montreal, Canada: Reiterated the Acrivon Therapeutics (ACRV.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $25.00 to $25.00.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment